Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson | 32 | 1 | 3 | 0 | €139.16 | €196.74 | 41.374% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.26 | €19.86 | 217.331% |
| Kezar Life Sciences | 5 | 0 | 1 | 0 | €0.75 | €18.56 | 2391.812% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €188.00 | €237.94 | 26.564% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €70.56 | €80.00 | 13.379% |
| Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €69.00 | €69.00 | 0.000% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.66 | €5.34 | 222.028% |
| Lightpath Techs A | 4 | 0 | 1 | 0 | €1.29 | €2.78 | 115.860% |
| MacroGenics Inc. | 14 | 0 | 5 | 0 | €3.07 | €15.52 | 404.746% |
| MannKind Corp. | 8 | 0 | 1 | 0 | €4.02 | €6.03 | 50.125% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €113.00 | €147.62 | 30.634% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €362.30 | €421.61 | 16.369% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
| Merit Medical Systems | 17 | 0 | 6 | 0 | €72.50 | €86.90 | 19.858% |
| Molina Healthcare | 12 | 1 | 1 | 0 | €329.30 | €366.73 | 11.366% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Myriad Genetics | 6 | 2 | 1 | 0 | €22.00 | €25.14 | 14.291% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.95 | - | - |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.63 | €3.70 | 126.994% |
| Neurocrine Bioscience | 27 | 0 | 6 | 0 | €126.90 | €140.34 | 10.591% |
| Novavax Inc. | 3 | 3 | 1 | 1 | €8.26 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €15.32 | - | - |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.00 | €47.53 | 76.030% |
| Patterson Companies Inc. | 6 | 0 | 0 | 0 | €23.60 | €32.18 | 36.365% |